(Q34188892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Directed evolution of novel adeno-associated viruses for therapeutic gene delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

M A Bartel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

D V Schaffer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

8 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

694-700

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22402323%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2012.20

25 January 2020

exact match

0 references

cites work

A viral assembly factor promotes AAV2 capsid formation in the nucleolus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Site-specific integration by adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Molecular engineering of viral gene delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Adeno-associated virus serotypes: vector toolkit for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Safety and efficacy of gene transfer for Leber's congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Effect of gene therapy on visual function in Leber's congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Exploring protein fitness landscapes by directed evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

DNA shuffling of adeno-associated virus yields functionally diverse viral progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Transposon-based mutagenesis generates diverse adeno-associated viral libraries with novel gene delivery properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Molecular evolution of adeno-associated virus for enhanced glial gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Isolation of targeted AAV2 vectors from novel virus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Human gene targeting by viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Interesting Times: Molecular Therapy and the Evolving Media of Scientific Publishing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Immune responses to AAV in a phase I study for Canavan disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Xenotropic murine leukemia virus-related virus is susceptible to AZT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Directed evolution of adeno-associated virus to an infectious respiratory virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Directed evolution of adeno-associated virus for glioma cell transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Mediating tumor targeting efficiency of nanoparticles through design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Clinical gene therapy using recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.20